• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. INDIGO SYSTEM FLASH ASPIRATION CATHETER; QEW

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. INDIGO SYSTEM FLASH ASPIRATION CATHETER; QEW Back to Search Results
Catalog Number LITNGFHT115BER
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Bradycardia (1751)
Date of Event 07/30/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This device is available for return.A follow up mdr will be submitted upon completion of the device investigation.
 
Event or Problem Description
On (b)(6) 2024, the patient underwent a thrombectomy procedure using an indigo system flash aspiration catheter.During the procedure, post first clot removal the patient experienced supra ventricular tachycardia (svt).Then the heart rate (hr) decreased (bradycardia) from 152 to 66 beats per minute (bpm), systolic blood pressure (bp) decreased from 134 mmhg to 109 mmhg which was likely a vagal episode.The event resolved with hr at 109 bpm.Atropine was administered and thrombus removal was continued.Svt was unrelated to the indigo system.Bradycardia was reported to be an adverse event with a possible relationship to the indigo system and a possible relationship to the index procedure.The event is considered resolved.
 
Additional Manufacturer Narrative
Please note that the device associated with this complaint was expected to be returned; however, the device is not available for return.The product was not returned for evaluation.Therefore, a physical device investigation was unable to be performed.From the information provided, there is no indication that there was any device malfunction, non conformance, or misuse that contributed to the reported event.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.H3 other text : placeholder.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INDIGO SYSTEM FLASH ASPIRATION CATHETER
Common Device Name
QEW
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
Manufacturer Contact
veronica farris
one penumbra place
alameda, CA 94502
5107483200
MDR Report Key20141482
Report Number3005168196-2024-00302
Device Sequence Number3226376
Product Code QEW
UDI-Device Identifier00815948029453
UDI-Public00815948029453
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
K240030
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Study,Health Professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/07/2024
Report Date (Section F) 01/01/2005
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberLITNGFHT115BER
Device Lot NumberF00010054
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report to Manufacturer01/10/2005
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/07/2024
Supplement Date Received by Manufacturer01/14/2005
Initial Report FDA Received Date09/04/2024
Supplement Report FDA Received Date11/08/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured10/19/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age57 YR
Patient SexMale
Date Report Sent to FDA01/01/2005
-
-